enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Abbott launches protein shake brand to help people on weight ...

    www.aol.com/news/abbott-launches-protein-shake...

    The drug class is expected to generate annual sales of more than $100 billion by the end of the decade, analysts said. Abbott intends to develop additional nutrition products and "conduct clinical ...

  3. Abbott Laboratories - Wikipedia

    en.wikipedia.org/wiki/Abbott_Laboratories

    Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, in the United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products.

  4. Sibutramine - Wikipedia

    en.wikipedia.org/wiki/Sibutramine

    The drug itself reaches its peak plasma level after 1 hour and has also a half-life of 1 hour. Sibutramine is metabolized by cytochrome P450 isozyme CYP3A4 into two pharmacologically active primary and secondary amines (called active metabolites 1 and 2) with half-lives of 14 and 16 hours, respectively. Peak plasma concentrations of active ...

  5. Abbott Pulls Weight Loss Drug Meridia from the Market - AOL

    www.aol.com/news/2010-10-08-abbott-weight-loss...

    Drug and medical-device maker Abbott Laboratories (ABT) announced Friday that it will voluntarily withdraw its controversial obesity drug Meridia, (sibutramine) from the U.S. market at the request ...

  6. Moxonidine - Wikipedia

    en.wikipedia.org/wiki/Moxonidine

    Moxonidine is a new-generation alpha-2/imidazoline receptor agonist antihypertensive drug licensed for the treatment of mild to moderate essential hypertension. [5] [6] It may have a role when thiazides, beta-blockers, ACE inhibitors, and calcium channel blockers are not appropriate or have failed to control blood pressure.

  7. Ozempic: GLP-1 Drugs May Help Prevent 34,000 Heart ... - AOL

    www.aol.com/lifestyle/ozempic-glp-1-drugs-may...

    GLP-1 drugs like Ozempic, Mounjaro, Wegovy, and Zepbound are powerful tools for treating diabetes and aiding with weight loss, but a new study suggests these medications could also help prevent ...

  8. Ritonavir - Wikipedia

    en.wikipedia.org/wiki/Ritonavir

    In 2003, Abbott (AbbVie, Inc.) raised the price of a Norvir course from US$1.71 per day to US$8.57 per day, leading to claims of price gouging by patients' groups and some members of Congress. Consumer group Essential Inventions petitioned the NIH to override the Norvir patent, but the NIH announced on August 4, 2004, that it lacked the legal ...

  9. Abbott’s plan to fight fentanyl overdoses won’t reach drug ...

    www.aol.com/abbott-plan-fight-fentanyl-overdoses...

    Abbott’s $10 million program, called One Pill Kills, creates a fentanyl public awareness campaign and funds the distribution of 20,000 doses of intranasal Narcan. That’s the brand name of ...